Early IL-17A Prevention Rather Than Late IL-17A Neutralization Attenuates Toluene Diisocyanate-Induced Mixed Granulocytic Asthma
Open Access
- 16 August 2022
- journal article
- research article
- Published by The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al in Allergy, Asthma & Immunology Research
- Vol. 14 (5) , 528-548
Abstract
Chen S, et al. Allergy Asthma Immunol Res. 2022 Sep;14(5):528-548. https://doi.org/10.4168/aair.2022.14.5.528Keywords
This publication has 35 references indexed in Scilit:
- Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodelingMucosal Immunology, 2012
- Leukocyte nicotinamide adenine dinucleotide phosphate-reduced oxidase is required for isocyanate-induced lung inflammationJournal of Allergy and Clinical Immunology, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and UveitisScience Translational Medicine, 2010
- Increased serum IL-17 is an independent risk factor for severe asthmaRespiratory Medicine, 2010
- Allergic Sensitization through the Airway Primes Th17-dependent Neutrophilia and Airway HyperresponsivenessAmerican Journal of Respiratory and Critical Care Medicine, 2009
- TH17-associated cytokines (IL-17A and IL-17F) in severe asthmaJournal of Allergy and Clinical Immunology, 2009
- IL-17–producing T cells in lung immunity and inflammationJournal of Allergy and Clinical Immunology, 2009
- Regulation of inflammatory responses by IL-17FJournal of Experimental Medicine, 2008
- Interleukin-17 is a negative regulator of established allergic asthmaJournal of Experimental Medicine, 2006